HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    


Top Stocks Set to Outperform
Over the Next 1 to 3 Months.
Click for your free picks >>
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

CNU: Continuecare Cp - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
CONTINUECARE CP (AMEX)
CNU 3.16 N/A (N/A%) Vol.  0 N/A ET
Continucare Corporation provides a continuum of outpatient and ancillary healthcare services with a primary focus on outpatient treatment of musculoskeletal injuries and diseases, such as arthritis, osteoporosis, stroke and traumatic injuries. The Company's services include physical rehabilitation, physician practice management, home healthcare, behavioral health management and laboratory services within its physician practices.

 General Information
CONTINUCARE CRP
7200 Corporate Center Drive
Suite 600
Miami, FL 33126
Phone: 305 500-2000
Fax: 305 350-9833
Web: www.continucare.com
Email: None
 
Industry MED-OUTP/HM CRE
Sector: Medical
 
Fiscal Year End June
Last Reported Quarter 09/30/09
Next EPS Date 02/04/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 3.16
52 Week High 3.29
52 Week Low 1.57
Beta 0.66
20 Day Moving Average 221,316.75
Target Price Consensus 5
 
 % Price Change
4 Week 7.32
12 Week 3.70
YTD 45.97
 % Price Change Relative to S&P 500
4 Week 6.16
12 Week -2.23
YTD 20.81
 Share Information
Shares Outstanding (millions) 59.41
Market Capitalization (millions) 182.99
Short Ratio 2.15
Last Split Date N/A
 Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 0.07
Current Year EPS Consensus Estimate 0.28
Estimated Long-Term EPS Growth Rate 20.00
Next EPS Report Date 02/04/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 1.00
30 Days Ago 1.00
60 Days Ago 1.00
90 Days Ago 1.00

 Fundamental Ratios
 P/E
Current FY Estimate: 11.00
Trailing 12 Months: 10.27
PEG Ratio 0.55
 EPS Growth
vs. Previous Year 125.00%
vs. Previous Quarter 12.50%
 Sales Growth
vs. Previous Year 16.76%
vs. Previous Quarter: 0.93%
 Price Ratios
Price/Book 1.56
Price/Cash Flow 10.40
Price / Sales 0.63
 ROE
09/30/09 16.52
06/30/09 14.37
03/31/09 13.01
 ROA
09/30/09 14.79
06/30/09 12.89
03/31/09 11.68
 Current Ratio
09/30/09 5.96
06/30/09 4.82
03/31/09 4.84
 Quick Ratio
09/30/09 5.96
06/30/09 4.82
03/31/09 4.84
 Operating Margin
09/30/09 6.19
06/30/09 5.43
03/31/09 5.01
 Net Margin
09/30/09 10.08
06/30/09 8.85
03/31/09 8.14
 Pre-Tax Margin
09/30/09 10.08
06/30/09 8.85
03/31/09 8.14
 Book Value
09/30/09 1.97
06/30/09 1.87
03/31/09 1.77
 Inventory Turnover
09/30/09 -
06/30/09 -
03/31/09 -
 Debt-to-Equity
09/30/09 0.00
06/30/09 0.00
03/31/09 0.00
 Debt to Capital
09/30/09 0.00
06/30/09 0.00
03/31/09 0.00

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research